Implant maker Aurora Spine's Q2 revenue falls, net loss widens on pain market weakness

Aurora Spine

27/08/2026 12:08

Overview
US spinal implant maker's fiscal Q2 revenue fell 19% yr/yr on lower pain market sales
Company posted wider net loss for fiscal Q2 as sales and gross margin declined
Management cites sales team transition, patent dispute, and competition as reasons for weak quarter

Outlook
Company expects continued growth in DEXA-C cervical implants and Apollo plates
Aurora expects strategic alliance with CornerLoc to broaden SI joint product offerings
Company believes updated sales team structure will support future growth

Result Drivers
PAIN MARKET DECLINE - Co said lower pain market activity and reduced SI joint product sales drove revenue decline
SALES TEAM TRANSITION - Management cited transition and retooling of internal sales team as a factor in weak quarter
DISTRIBUTOR SALES MIX - Increased sales through distributor network contributed to lower gross margins

Company press release: ID:nNFC85DSP3

Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q2 Operating Expenses
 
$3.03 mln
 

Analyst Coverage
The stock recently traded at 1 times the next 12-month earnings vs. a P/E of 2 three months ago

Reuters Recommended Reads
Aug 26 - China's AK Medical interim profit rises on overseas, digital sales
Aug 27 - Belgium's Materialise NV Q2 revenue rises 8% on medical segment strength
Aug 25 - Electromed's Q4 revenue slightly beats estimates on homecare strength

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)